Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fibrinogen--proteolysis in acute myelogenous leukemia (AML).

Literature DB >> 2941088

Fibrinogen--proteolysis in acute myelogenous leukemia (AML).

Abstract

Fibrinopeptides were measured as direct indices of thrombin, plasmin and elastase in plasma samples obtained from patients with AML. Peptide patterns observed were consistent with spontaneous or drug induced plasmin-specific fibrinogenolysis (AML FAB M 1/3), elastase mediated proteolysis (AML FAB M 3/4) or DIC (AML FAB 4/5). DIC was also observed in septic, agranulocytotic patients.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 1986 PMID： 2941088 DOI： 10.1007/bf00320581

Source DB: PubMed Journal: Blut ISSN： 0006-5242

22 in total

1. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.

Authors: L Sterrenberg; G J van Liempt; W Nieuwenhuizen; J Hermans
Journal: Thromb Haemost Date: 1984-07-29 Impact factor: 5.249

2. Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays.

Authors: H L Nossel; V P Butler; G D Wilner; R E Canfield; E J Harfenist
Journal: Thromb Haemost Date: 1976-02-29 Impact factor: 5.249

3. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.

Authors: M Gramse; C Bingenheimer; W Schmidt; R Egbring; K Havemann
Journal: J Clin Invest Date: 1978-04 Impact factor: 14.808

4. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.

Authors: E F Plow
Journal: J Clin Invest Date: 1982-03 Impact factor: 14.808

10. Cytochemical determination of granulocyte elastase and chymotrypsin in human myeloid cells and its application in acquired deficiency states and diagnosis of myeloid leukemia.

Authors: K Havemann; M Gramse; W D Gassel
Journal: Klin Wochenschr Date: 1983-01-03

2 in total

1. The importance of granulocyte elastase in haematological diagnosis.

Authors: J Hastka
Journal: Blut Date: 1988-08

2. Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.

Authors: F Rodeghiero; G Castaman; G Soffiati; R Quaglio; S Castronovo; S Cortesi; E Dini
Journal: Blut Date: 1989-08

2 in total

Fibrinogen--proteolysis in acute myelogenous leukemia (AML).

1. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.

2. Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays.

3. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.

4. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.

5. The major fibrinolytic proteases of human leukocytes.

6. The significance of fibrinogen derivatives in plasma in human renal failure.

7. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

8. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.

9. Measurement of desarginine fibrinopeptide B in human blood.

10. Cytochemical determination of granulocyte elastase and chymotrypsin in human myeloid cells and its application in acquired deficiency states and diagnosis of myeloid leukemia.

1. The importance of granulocyte elastase in haematological diagnosis.

2. Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.